Clinical Trial Update: A Randomized Controlled Trial Evaluating One Drop | Premium With Afrezza vs. One Drop | Premium Alone [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing One Drop Premium with Afrezza vs One Drop Premium alone in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)
• One Drop Premium
• One Drop Premium with Afrezza

Snippet

Sponsor: Informed Data Systems, Inc. | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN